Search papers, labs, and topics across Lattice.
Tri-Institutional Therapeutics Discovery Institute, New York, NY, USA
1
0
0
1
An approach to potentially cure myeloproliferative neoplasms is established by proving mutant calreticulin to be a MPN stem cell marker that can be targeted by CAR-T cells to selectively wipe out disease in preclinical models of human MPNs.
